144 related articles for article (PubMed ID: 27114913)
1. Association of somatic burden of disease with age and neuropsychological measures in attenuated mucopolysaccharidosis types I, II and VI.
Ahmed A; Shapiro E; Rudser K; Kunin-Batson A; King K; Whitley CB
Mol Genet Metab Rep; 2016 Jun; 7():27-31. PubMed ID: 27114913
[TBL] [Abstract][Full Text] [Related]
2. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
[TBL] [Abstract][Full Text] [Related]
3. Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and Validity.
Ahmed A; Rudser K; Kunin-Batson A; Delaney K; Whitley C; Shapiro E
JIMD Rep; 2016; 26():61-8. PubMed ID: 26303610
[TBL] [Abstract][Full Text] [Related]
4. Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.
Yund B; Rudser K; Ahmed A; Kovac V; Nestrasil I; Raiman J; Mamak E; Harmatz P; Steiner R; Lau H; Vekaria P; Wozniak JR; Lim KO; Delaney K; Whitley C; Shapiro EG
Mol Genet Metab; 2015 Feb; 114(2):170-7. PubMed ID: 25541100
[TBL] [Abstract][Full Text] [Related]
5. The natural history of neurocognition in MPS disorders: A review.
Shapiro EG; Eisengart JB
Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II.
Shapiro EG; Rudser K; Ahmed A; Steiner RD; Delaney KA; Yund B; King K; Kunin-Batson A; Eisengart J; Whitley CB
Mol Genet Metab Rep; 2016 Jun; 7():32-9. PubMed ID: 27114914
[TBL] [Abstract][Full Text] [Related]
7. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
[TBL] [Abstract][Full Text] [Related]
8. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
[TBL] [Abstract][Full Text] [Related]
9. Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.
Shapiro EG; Nestrasil I; Rudser K; Delaney K; Kovac V; Ahmed A; Yund B; Orchard PJ; Eisengart J; Niklason GR; Raiman J; Mamak E; Cowan MJ; Bailey-Olson M; Harmatz P; Shankar SP; Cagle S; Ali N; Steiner RD; Wozniak J; Lim KO; Whitley CB
Mol Genet Metab; 2015; 116(1-2):61-8. PubMed ID: 26095521
[TBL] [Abstract][Full Text] [Related]
10. Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10-year prospective study.
Miller BS; Fung EB; White KK; Lund TC; Harmatz P; Orchard PJ; Whitley CB; Polgreen LE
J Inherit Metab Dis; 2023 Jul; 46(4):695-704. PubMed ID: 36840680
[TBL] [Abstract][Full Text] [Related]
11. [Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].
Giugliani R; Federhen A; Muñoz Rojas MV; Vieira TA; Artigalás O; Pinto LL; Azevedo AC; Acosta AX; Bomfim C; Lourenço CM; Kim CA; Horovitz D; Souza DB; Norato D; Marinho D; Palhares D; Santos ES; Ribeiro E; Valadares ER; Guarany F; De Lucca GR; Pimentel H; Souza IN; Corrêa Neto J; Fraga JC; Góes JE; Cabral JM; Simeonato J; Llerena JC; Jardim LB; Giuliani Lde R; Silva LC; Santos M; Moreira MA; Kerstenetzky M; Ribeiro M; Ruas N; Barrios P; Aranda P; Honjo R; Boy R; Costa R; Souza CF; Alcântara FF; Avilla SG; Fagondes S; Martins AM
Rev Assoc Med Bras (1992); 2010; 56(3):271-7. PubMed ID: 20676532
[TBL] [Abstract][Full Text] [Related]
12. Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil: A Multicenter Study.
Bitencourt FH; Vieira TA; Steiner CE; Neto JC; Boy R; Schwartz IVD
Value Health Reg Issues; 2015 Dec; 8():99-106. PubMed ID: 29698178
[TBL] [Abstract][Full Text] [Related]
13. Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI.
Polgreen LE; Vehe RK; Rudser K; Kunin-Batson A; Utz JJ; Dickson P; Shapiro E; Whitley CB
Mol Genet Metab; 2016 Apr; 117(4):427-30. PubMed ID: 26873528
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.
Akyol MU; Alden TD; Amartino H; Ashworth J; Belani K; Berger KI; Borgo A; Braunlin E; Eto Y; Gold JI; Jester A; Jones SA; Karsli C; Mackenzie W; Marinho DR; McFadyen A; McGill J; Mitchell JJ; Muenzer J; Okuyama T; Orchard PJ; Stevens B; Thomas S; Walker R; Wynn R; Giugliani R; Harmatz P; Hendriksz C; Scarpa M; ;
Orphanet J Rare Dis; 2019 May; 14(1):118. PubMed ID: 31142378
[TBL] [Abstract][Full Text] [Related]
15. Current and potential therapeutic strategies for mucopolysaccharidoses.
Noh H; Lee JI
J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
[TBL] [Abstract][Full Text] [Related]
16. Galsulfase: arylsulfatase B, BM 102, recombinant human arylsulfatase B, recombinant human N-acetylgalactosamine-4-sulfatase, rhASB.
Drugs R D; 2005; 6(5):312-5. PubMed ID: 16128602
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
[TBL] [Abstract][Full Text] [Related]
18. Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy.
Lin HY; Chen MR; Lee CL; Lin SM; Hung CL; Niu DM; Chang TM; Chuang CK; Lin SP
Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33374885
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Evaluation using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses.
Lin HY; Chuang CK; Lee CL; Chen MR; Sung KT; Lin SM; Hou CJ; Niu DM; Chang TM; Hung CL; Lin SP
Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979324
[TBL] [Abstract][Full Text] [Related]
20. Functional capacity evaluation of patients with mucopolysaccharidosis.
Guarany NR; Schwartz IV; Guarany FC; Giugliani R
J Pediatr Rehabil Med; 2012; 5(1):37-46. PubMed ID: 22543891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
